Mad Honey Finder Learn
← Back to Mad Honey Finder
What sellers can — and cannot — claim.
The line between a structure-function claim and a disease claim can be the line between a legal business and an FDA warning letter.
What can mad-honey sellers legally claim?
In the United States, sellers can make structure-function claims ("supports relaxation," "traditionally used for…") with the FDA disclaimer that the product is not intended to diagnose, treat, cure, or prevent any disease. They cannot claim it treats specific diseases. In the EU and UK, only pre-approved health claims may appear on food — mad honey has none. Disease-treatment claims anywhere in the world require drug approval the seller does not have.
Structure-function vs disease claims
The Federal Food, Drug, and Cosmetic Act (FFDCA) and the Dietary Supplement Health and Education Act (DSHEA) create a two-tier framework. The difference between the tiers determines whether your product is a food or an unapproved drug.
Structure-function claims
Statements about how the product affects normal body structure or function. No pre-market FDA approval required if paired with the DSHEA disclaimer.
- +"Traditionally used for relaxation and calm"
- +"Supports a sense of well-being"
- +"Enjoyed by honey hunters for centuries"
- +"Part of traditional Nepalese wellness practice"
Disease claims
Statements that the product treats, prevents, or mitigates a specific disease. Converts the product into an unapproved drug — warning letter, injunction, or criminal referral.
- −"Treats anxiety"
- −"Lowers blood pressure for patients with hypertension"
- −"Helps with erectile dysfunction"
- −"Cures insomnia"
- −"Prevents cardiovascular disease"
Medical claims rules by region
United States
European Union
United Kingdom
Canada
Australia / NZ
Mad honey's specific exposure: enhancement claims
Mad honey is frequently marketed with male-enhancement undertones. This is a particularly high-risk category because of the FDA's aggressive enforcement on the broader "honey + undeclared sildenafil" problem — see our sister site HoneyPackFinder for the FDA alert archive.
Editorial advice to sellers: stay well away from this category in marketing copy, even for truthful adjacent claims.
The FDA disclaimer is useful cover
"These statements have not been evaluated by the FDA" works for structure-function claims. It does not legalize disease claims. Regulators apply a "reasonable consumer" standard — if the overall impression conveys disease treatment, the disclaimer does not save you.
This site isn't a seller
Mad Honey Finder is an editorial platform. We can discuss historical, traditional, and clinical uses with journalistic posture. A seller doing the same on a product page faces a different regulatory analysis — commercial speech attaches to intent to sell. Do not copy our editorial language to product pages.
What safe marketing copy looks like
- ✓Describe the product factually (origin, potency, testing)
- ✓Use traditional-use framing in past tense, not therapeutic present
- ✓Include the FDA disclaimer prominently (US)
- ✓Avoid any disease name
- ✓Avoid "improves," "treats," "prevents," "cures" language
- ✓Encourage medical consultation in the disclaimer
Mad honey sits in a category where the pharmacology is real and the marketing temptation is strong. The sellers who survive long-term are the ones who resist the temptation. Factual sourcing, factual testing, conservative claims. That is the durable play.